Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 19, Issue 6, Pages 777-788
Publisher
Informa Healthcare
Online
2010-05-13
DOI
10.1517/13543784.2010.489548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FERM control of FAK function: Implications for cancer therapy
- (2014) Ssang-Taek Lim et al. CELL CYCLE
- Paradoxical roles of FAK in tumor cell migration and metastasis
- (2011) Yanhua Zheng et al. CELL CYCLE
- A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer
- (2011) Steven N. Hochwald et al. CELL CYCLE
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
- (2010) Cedo M Bagi et al. CANCER BIOLOGY & THERAPY
- Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models
- (2010) Colin Walsh et al. CANCER BIOLOGY & THERAPY
- Expression of Focal Adhesion Kinase in Patients With Endometrial Cancer
- (2010) Boris Gabriel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Extracellular matrix-induced transforming growth factor-β receptor signaling dynamics
- (2010) N Garamszegi et al. ONCOGENE
- The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis
- (2009) Vita M Golubovskaya et al. BMC CANCER
- Signal transduction by focal adhesion kinase in cancer
- (2009) Jihe Zhao et al. CANCER AND METASTASIS REVIEWS
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- Targeting Focal Adhesion Kinase with Dominant-Negative FRNK or Hsp90 Inhibitor 17-DMAG Suppresses Tumor Growth and Metastasis of SiHa Cervical Xenografts
- (2009) J. Schwock et al. CANCER RESEARCH
- Knockdown of focal adhesion kinase reverses colon carcinoma multicellular resistance
- (2009) Yu-Ying Chen et al. CANCER SCIENCE
- SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer
- (2009) Fred Saad et al. CANCER TREATMENT REVIEWS
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Targeting Pyk2 for therapeutic intervention
- (2009) Christopher A Lipinski et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The effect of focal adhesion kinase gene silencing on 5-fluorouracil chemosensitivity involves an Akt/NF-κB signaling pathway in colorectal carcinomas
- (2009) Yuying Chen et al. INTERNATIONAL JOURNAL OF CANCER
- Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design
- (2009) Seungil Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines
- (2009) Wu Huanwen et al. Molecular Cancer
- Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
- (2009) K. Sakurama et al. MOLECULAR CANCER THERAPEUTICS
- Expression and Clinical Significance of Focal Adhesion Kinase in the Two Distinct Histological Types, Intestinal and Diffuse, of Human Gastric Adenocarcinoma
- (2009) Constantinos T. Giaginis et al. PATHOLOGY & ONCOLOGY RESEARCH
- Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer
- (2008) Paolo P. Provenzano et al. AMERICAN JOURNAL OF PATHOLOGY
- TAE226 Inhibits Human Neuroblastoma Cell Survival
- (2008) Elizabeth A. Beierle et al. CANCER INVESTIGATION
- Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
- (2008) W. G. Roberts et al. CANCER RESEARCH
- Focal Adhesion Kinase: Targeting Adhesion Signaling Pathways for Therapeutic Intervention
- (2008) J. T. Parsons et al. CLINICAL CANCER RESEARCH
- Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma In vitro and In vivo
- (2008) N. Watanabe et al. CLINICAL CANCER RESEARCH
- ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
- (2008) R. Schmidmaier et al. CURRENT MEDICINAL CHEMISTRY
- Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK
- (2008) Sara M. Weis et al. JOURNAL OF CELL BIOLOGY
- Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway
- (2008) Leticia Oliveira-Ferrer et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Small Molecule Inhibitor, 1,2,4,5-Benzenetetraamine Tetrahydrochloride, Targeting the Y397 Site of Focal Adhesion Kinase Decreases Tumor Growth
- (2008) Vita M. Golubovskaya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia
- (2008) Emmanuelle Tavernier-Tardy et al. LEUKEMIA RESEARCH
- TAE226-Induced apoptosis in breast cancer cells with overexpressed Src or EGFR
- (2007) Vita M. Golubovskaya et al. MOLECULAR CARCINOGENESIS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started